Fig. 4From: Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trialThe graph shows the mean change in potassium. The bars indicate median and interquartile range change in potassium over the 24 weeks in the lithium and placebo arms respectivelyBack to article page